In 1847, Ignaz Semmelweis marked a turning point in medicine in Vienna with hand hygiene – and it was particularly the meticulous observations of midwives that helped to make the connection between cleanliness and survival visible. This episode teaches us: Early detection saves lives when we pay close attention and act systematically. For men today, this means: Preventive care is not a luxury, but a performance tool – precise, planned, and effective.

Preventive examinations identify risks before they show symptoms. Blood pressure measurement uncovers Hypertensionchronically elevated blood pressure that damages vessels and organs – often silently. Blood sugar checks identify Prediabetesthe precursor of type 2 diabetes with elevated glucose levels, when countermeasures can still be taken. Colonoscopycolon examination for the discovery and removal of precursors to colon cancer finds polyps before they become malignant. Skin cancer screening examines skin areas for new or changed lesions; if abnormalities are found, dermatoscopy or biopsy follows. For high performers, the principle is simple: The earlier the measurement, the greater the leverage for longevity, heart-brain protection, and sustained energy.

Uncontrolled blood pressure accelerates arteriosclerosis, increases stroke and heart attack risk, and diminishes cognitive performance – often remaining undetected. A study from a humanitarian setting showed: More than half of adults had elevated values; many were aware of it, but only a small part was well-managed – clear evidence that simple, regular measurements are necessary ^[1]. The same applies to type 2 diabetes: It is often undetected, advances cardiovascular, nerve, and kidney damage, and robs energy. A large-scale French screening identified previously hidden cases and confirmed obesity as a strong risk factor – early detection prevents late complications ^[2]. Colon cancer can be practically “reversed” through polyp removal: Modeling with German registry data shows that a single colonoscopy between ages 50 and 65 significantly reduces mortality risk – optimal for men in their mid-50s, earlier with series screenings ^[3]. Concurrently, US data warns: Cases among those under 55 are increasing; therefore, the starting age for average-risk individuals has been lowered to 45 years – symptoms like blood in stool or unexplained weight loss require immediate clarification, regardless of age ^[4]. In the case of skin cancer, new analyses in Germany have shown no clear mortality advantage of broad screening, which does not argue against vigilance but suggests more targeted strategies and high quality in examinations ^[5].

The evidence for colorectal cancer prevention is particularly strong: A Markov model based on the German colonoscopy register simulated life courses of unfiltered 50-year-olds and compared different starting ages and intervals. The result: A one-time colonoscopy between ages 50 and 65 substantially reduced deaths and lost life years; the optimal age mark was just past mid-50s for men, and with repeat colonoscopies, the start age moves to 50 or younger ^[3]. Additionally, recent US epidemiologies show an increase in early-onset cases, justifying the advancement of routine screenings to 45 years and an early diagnostic approach for warning symptoms – relevant in practice because lifestyle cohorts after 1950 exhibit different risk profiles ^[4]. For hypertension, a cross-sectional study in an exceptional situation documents that even a simple one-time measurement reveals high rates of elevated values and that the care chain is often fragile – an indication that low-threshold screening and clear follow-up paths are essential ^[1]. In diabetes, a large, practice-relevant evaluation of a workplace screening demonstrates that systematic glucose measurements bring previously undetected cases to light, especially among those with obesity, thereby activating preventive care early ^[2]. Finally, an international comparative analysis of skin cancer screening suggests that the population-wide program in Germany so far does not provide a measurable mortality advantage; for practice, this means: Quality, risk stratification, and consistent clarification of noticeable lesions are crucial ^[5].

- Blood pressure: Measure at home 1–2 times per week, in the morning before coffee and exercise. Use an upper arm cuff; sit quietly for 5 minutes, take two measurements one minute apart, and note the average. Values ≥135/85 mmHg (home measurement) should be clarified by a doctor and therapy pursued consistently – the goal is control, not just awareness ^[1].
- Blood sugar: Have fasting glucose or HbA1c determined annually; if overweight, with a family history, or low activity, do so semi-annually. Utilize occupational health services – they often uncover undetected cases and enable early intervention ^[2].
- Colon cancer: Start with a colonoscopy no later than 50, ideally even earlier with series screenings; inquire about the lowered starting ages (45 years for average risk, from 40 for high risk), and seek immediate medical clarification if there is blood in stool, weight loss, pain, or changes in bowel habits – age offers no protection here ^{[3] [4]}.
- Skin: Conduct annual self-examinations (photographs of moles, ABCDE rule) and dermatological checks at individually reasonable intervals. Focus more on the quality of the examination and timely clarification of noticeable lesions than on rigid 2-year rhythms, as population-wide programs have so far shown no clear mortality advantage ^[5].

The future of preventive care will be personalized: Data from wearables, home measurements, and smart risk stratification will converge into clear, individualized screening paths. Expect guidelines that shift age thresholds based on risk profiles – aiming to eliminate silent risks earlier and more precisely.